Actively Recruiting

Phase Not Applicable
Age: 20Years - 40Years
FEMALE
Healthy Volunteers
NCT07437248

Leucine Requirements During Pregnancy

Led by University of British Columbia · Updated on 2026-04-22

40

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to understand how much leucine, an essential amino acid, and protein building block, healthy pregnant women need during early and late pregnancy. Leucine plays an important role in supporting muscle health and fetal growth. Participants will consume carefully prepared meals and provide breath, urine samples, and one blood sample so researchers can measure how the body uses leucine at different stages of pregnancy. The results will help improve nutrition guidelines for pregnant women to better support maternal health and healthy fetal development.

CONDITIONS

Official Title

Leucine Requirements During Pregnancy

Who Can Participate

Age: 20Years - 40Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women aged 20 to 40 years
  • Singleton pregnancy
  • Gestational age of 11 to 20 weeks (early) or 31 to 40 weeks (late)
  • Participants in early gestation may participate again in late gestation if eligible
  • Good general health with no acute or chronic medical conditions
  • Fully ambulatory and able to follow study procedures
  • Pre-pregnancy BMI between 19 and 28 kg/m²
  • Carrying a viable pregnancy without known complications at enrollment
Not Eligible

You will not qualify if you...

  • Pregnancy-related complications such as hyperemesis gravidarum, gestational diabetes, hypertension, pre-eclampsia, or anemia
  • History of adverse pregnancy outcomes like spontaneous abortion or preterm birth
  • Multiple gestation pregnancies
  • Pregnancy loss within six months before current pregnancy
  • Chronic metabolic, cardiovascular, neurological, genetic, or immune disorders
  • Clinically significant claustrophobia
  • Use of alcohol, tobacco, or illicit substances during pregnancy
  • Gestational weight loss greater than 1.5 kg
  • Pre-pregnancy BMI outside 19 to 28 kg/m²

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

BC Children's Hospital Research Institute

Vancouver, British Columbia, Canada, V5Z 4H4

Actively Recruiting

Loading map...

Research Team

L

Layan El Rifai, Graduate Student

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here